Abdominal giant lymph node hyperplasia (Castleman’s disease): report of two cases

[1] Castleman B., Iverson L., Menedez V.P. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer., 1956, 9, 822–830 http://dx.doi.org/10.1002/1097-0142(195607/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-410.1002/1097-0142(195607/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4Search in Google Scholar

[2] Bhatti M. A.K., Ferrante J.W., Gielchinsky I., Norman J.C. Giant lymph node hyperplasia of the mediastinum (castleman’s disease): case report and review. Tex Heart Inst J., 1984, 11: 378–384 Search in Google Scholar

[3] Kim J. H., Jun T.G., Sung S.W., Shim Y.S., Han S.K., Kim Y.W., Yoo C.G., Seo J.W., Rho J.R. Giant lymph node hyperplasia (Castleman’s disease) in the chest. Ann Thorac Surg., 1995, 59: 1162–1165 http://dx.doi.org/10.1016/0003-4975(95)00068-V10.1016/0003-4975(95)00068-VSearch in Google Scholar

[4] Seirafi P. A., Ferguson E., Edwards F.H. Thoracoscopic resection of Castleman disease: case report and review. Chest., 2003, v123:280–282 http://dx.doi.org/10.1378/chest.123.1.28010.1378/chest.123.1.280Search in Google Scholar

[5] Bandera B., Ainsworth C., Shikle J., Rupard E., Roach M. Treatment of unicentric castleman disease with neoadjuvant rituximab. Chest., 2010, 138: 1239–1241 http://dx.doi.org/10.1378/chest.09-208410.1378/chest.09-2084Search in Google Scholar

[6] Rena O., Casadio C., Maggi G. Castleman’s disease: unusual intrathoracic localization Eur J Cardiothorac Surg., 2001, 19, 519–521. http://dx.doi.org/10.1016/S1010-7940(01)00613-310.1016/S1010-7940(01)00613-3Search in Google Scholar

[7] Weisenburger D. D., Nathwani B.N., Winberg C.D., Rappaport H. Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases. Hum Pathol., 1985,16:162–172 http://dx.doi.org/10.1016/S0046-8177(85)80065-410.1016/S0046-8177(85)80065-4Search in Google Scholar

[8] Slotwiner A., Garwacki C.P., Moll S. Castleman’s disease. Am J Hematol., 2003,73:64–65 http://dx.doi.org/10.1002/ajh.1031810.1002/ajh.10318Search in Google Scholar

[9] McAdams H. P., Rosado-de-Christenson M.R., Fishback N.F., Templeton P.A. Castleman disease Of the thorax: radiologic features with clinical and histopatholigic correlation. Radiology., 1998, 209, 221–228 10.1148/radiology.209.1.9769835Search in Google Scholar

[10] Kim M. H., Hwang S., Choi Y.B., Oh S.T., Kim S.C., Choi G.M., Ahn C.S., Kim K.H., Moon D.B., Ha T.Y., Song G.W., Jung D.H., Yu E.S., Lee S.G. Castleman disease of the abdomen—single-center experience of 13 surgically treated patients over 11 years. Hepato-Gastroenterol., 2010, 57, 1060–1063 Search in Google Scholar

[11] Dispenzieri A., Gertz M.A. Treatment of Castleman’s disease. Curr Treat Options Oncol., 2005, 6, 255–266 http://dx.doi.org/10.1007/s11864-005-0008-z10.1007/s11864-005-0008-zSearch in Google Scholar

[12] Chronowski G. M., Ha C.S., Wilder R.B., Cabanillas F., Manning J., Cox J.M. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer. 2001, 92, 670. http://dx.doi.org/10.1002/1097-0142(20010801)92:3<670::AID-CNCR1369>3.0.CO;2-Q10.1002/1097-0142(20010801)92:3<670::AID-CNCR1369>3.0.CO;2-QSearch in Google Scholar

[13] Powles T., Stebbing J., Bazeos A., Hatzimichael, E., Mandalia, S., Nelson, M., Gazzard, B., Bower, M. The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman’s disease. Ann Oncol., 2009, 20, 775–779 http://dx.doi.org/10.1093/annonc/mdn69710.1093/annonc/mdn697Search in Google Scholar PubMed

[14] van Rhee F., Fayad L., Voorhees P., Furman R., Lonial S., Borghaei H., Sokol L., Crawford J., Cornfeld M., Qi M., Qin X., Herring J., Casper C., Kurzrock R. Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman’s disease. J Clin Oncol., 2010, 28, 3701–3708 http://dx.doi.org/10.1200/JCO.2009.27.237710.1200/JCO.2009.27.2377Search in Google Scholar PubMed